newsfilter
← Latest News
GlobeNewswire·

Coherus Oncology Reports Third Quarter 2026 Financial Results and Announces Strategic Prioritization Plan

– Focus development efforts on tagmokitug/toripalimab as a potential best-in-disease treatment for esophageal cancer with plans for expedited development – – Deprioritize development of tagmokitug/toripalimab in other